Combination Chemotherapy for 3 Months or 6 Months in Treating Patients With Stage III Colon Cancer
Status:
Unknown status
Trial end date:
2017-09-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as oxaliplatin, leucovorin calcium, and
fluorouracil, work in different ways to stop the growth of tumor cells, either by killing the
cells or by stopping them from dividing. It is not yet known whether giving more than one
drug (combination chemotherapy) is more effective when given for 3 months or 6 months in
treating patients with colon cancer.
PURPOSE: This randomized phase III trial is studying giving combination chemotherapy for 3
months to see how well it works compared with giving combination chemotherapy for 6 months in
treating patients with stage III colon cancer.
Phase:
Phase 3
Details
Lead Sponsor:
GERCOR - Multidisciplinary Oncology Cooperative Group Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)